- Conditions: Acute Lymphoblastic Leukemia; Precursor B-Cell Lymphoblastic Leukemia; Precursor T-Cell Lymphoblastic Leukemia
Interventions: Drug: Decitabine; Drug: Vorinostat; Drug: Vincristine; Drug: Dexamethasone; Drug: Mitoxantrone; Drug: Pegaspargase; Drug: Methotrexate
Sponsors: Therapeutic Advances in Childhood Leukemia Consortium; Therapeutic Advances in Childhood Leukemia Consortium
Recruiting - verified March 2012 - Condition: Ulcerative Colitis
Interventions: Drug: Rectal tactolimus; Drug: Placebo
Sponsors: The University of Western Australia; The University of Western Australia; Mater Health Services' Adult Hospital, Brisbane, Qld; Concord Hospital; The Canberra Hospital; Royal Prince Alfred Hospital, Sydney, Australia
Not yet recruiting - verified August 2011 - Conditions: Prostate Cancer (Post Prostatectomy); Anal Cancer; Nasopharyngeal Cancer; Intermediate Risk Prostate Cancer
Intervention: Other: Non-Interventional Study
Sponsors: Trans-Tasman Radiation Oncology Group (TROG); Trans-Tasman Radiation Oncology Group (TROG)
Recruiting - verified June 2011 - Condition: Critically Injured Mechanically Ventilated Trauma Patients
Interventions: Other: Protective manual hyperinflation; Other: Usual method of MHI
Sponsors: The University of Queensland; The University of Queensland; Royal Brisbane and Women's Hospital
Active, not recruiting - verified November 2010 - Condition: Sepsis Syndromes
Interventions: Other: Exercise; Other: Usual practice
Sponsors: The University of Queensland; The University of Queensland; Royal Brisbane and Women's Hospital
Active, not recruiting - verified October 2008 - Condition: Burns
Intervention: Other: Intensive exercise
Sponsors: The University of Queensland; The University of Queensland; Royal Brisbane and Women's Hospital
Active, not recruiting - verified November 2010 - Condition: Idiopathic Pulmonary Fibrosis
Intervention: Other: Placental MSC
Sponsors: The Prince Charles Hospital; The Prince Charles Hospital; Mater Medical Research Institute
Recruiting - verified September 2009 - Condition: Acute Hepatitis C
Interventions: Drug: Peginterferon alfa-2a; Drug: Ribavirin
Sponsors: Kirby Institute; Kirby Institute
Not yet recruiting - verified April 2011 - Conditions: Respiratory Tract Infections; Gastrointestinal Infections
Intervention:
Sponsors: Queensland Children's Medical Research Institute; Queensland Children's Medical Research Institute; Royal Brisbane and Women's Hospital
Recruiting - verified June 2011 - Conditions: Cystic Fibrosis; Bronchiectasis
Interventions: Drug: Azithromycin; Drug: Placebo control
Sponsors: Queensland Children's Medical Research Institute; Queensland Children's Medical Research Institute; Telethon Institute for Child Heath Research
Enrolling by invitation - verified May 2012 - Condition: Traumatic Brain Injury
Interventions: Drug: Paracetamol; Drug: 0.9% Sodium Chloride Schedule:
Sponsors: South East Sydney and Illawarra Area Health Service; South East Sydney and Illawarra Area Health Service; The George Institute; The University of New South Wales; Royal Brisbane and Women's Hospital
Recruiting - verified May 2010 - Conditions: Bronchiolitis Obliterans; Lung Transplantation
Intervention: Other: MSC
Sponsors: The Prince Charles Hospital; The Prince Charles Hospital; Cell & Tissue Therapies Western Australia
Recruiting - verified July 2011 - Condition: Delirium
Interventions: Drug: Dexmedetomidine; Drug: Saline placebo
Sponsors: Austin Health; Austin Health; Hospira Pty Ltd
Recruiting - verified May 2010 - Condition: Ankle Fractures
Interventions: Procedure: Open reduction internal fixation of the ankle; Procedure: Non Operative
Sponsors: The University of New South Wales; The University of New South Wales; Whitlam Orthopaedic Research Centre; CROSSBAT Investigators
Recruiting - verified January 2012 - Conditions: Reverse Oblique Intertrochanteric Fractures; Reverse Oblique Subtrochanteric Fractures
Interventions: Device: Proximal femur locking plate; Device: Intertrochanteric nail
Sponsors: AO Clinical Investigation and Documentation; AO Clinical Investigation and Documentation
Recruiting - verified January 2012 - Conditions: Infant, Premature, Diseases; Bronchopulmonary Dysplasia; Retinopathy of Prematurity; Infant, Newborn, Diseases; Infant, Very Low Birth Weight
Interventions: Procedure: Higher oxygen saturation target range (91%-95%); Procedure: Lower oxygen saturation (85%-89%)
Sponsors: University of Sydney; University of Sydney; University of Otago; University of Oxford; University of Pennsylvania; University of California, San Diego
Recruiting - verified August 2011 - Condition: Spinal Cord Injury
Interventions: Device: ReJoyce Workstation; Other: Standard Care
Sponsors: University of Melbourne; University of Melbourne; Victorian Neurotrauma Initiative; Lifetime Care and Support Authority (NSW); The University of Western Australia
Recruiting - verified March 2010 - Condition: Endometrial Cancer
Intervention:
Sponsors: Queensland Centre for Gynaecological Cancer; Queensland Centre for Gynaecological Cancer; Greenslopes Private Hospital; The University of Queensland; Sullivan and Nicolaides Pathology
Recruiting - verified June 2011 - Condition: Stage IV Resectable Melanoma
Interventions: Procedure: Surgery; Procedure: Surgery plus 2 adjuvant doses of BCG; Other: best medical therapy
Sponsors: John Wayne Cancer Institute; John Wayne Cancer Institute; Melanoma Research Alliance
Recruiting - verified May 2012 - Condition: Traumatic Brain Injury
Interventions: Drug: Epoetin Alfa; Drug: Placebo, Sodium Chloride
Sponsors: Australian and New Zealand Intensive Care Research Centre; Australian and New Zealand Intensive Care Research Centre; National Health and Medical Research Council, Australia; Victorian Neurotrauma Initiative; Australian and New Zealand Intensive Care Society Clinical Trials Group; Monash University
Recruiting - verified April 2012 - Condition: Severe Sepsis
Interventions: Other: Standard Care; Other: Early Goal Directed Therapy (EGDT)
Sponsors: Monash University; Belinda Howe; Australian and New Zealand Intensive Care Society Clinical Trials Group; Australasian College for Emergency Medicine
Recruiting - verified April 2012 - Condition: Stroke
Interventions: Drug: Tissue Plasminogen Activator (Alteplase); Drug: Placebo
Sponsors: National Stroke Research Institute, Australia; National Stroke Research Institute, Australia; Commonwealth Scientific & Industry Research Organisation; Brain Research Institute; University of Melbourne; Melbourne Health
Recruiting - verified May 2012 - Conditions: Breast Neoplasms; Heart Failure
Intervention:
Sponsors: Royal Prince Alfred Hospital, Sydney, Australia; Royal Prince Alfred Hospital, Sydney, Australia
Recruiting - verified July 2011 - Conditions: Epithelial Ovarian Cancer; Primary Peritoneal Cancer; Fallopian Tube Cancer
Intervention: Other: Enteral feeding
Sponsors: Queensland Centre for Gynaecological Cancer; Queensland Centre for Gynaecological Cancer; Cancer Australia; The University of Queensland
Recruiting - verified June 2011 - Condition: Distal Radius Fractures
Interventions: Procedure: volar locking plating; Procedure: external immobilisation
Sponsors: Mackay Base Hospital; Mackay Base Hospital; James Cook University, Queensland, Australia
Recruiting - verified July 2010 - Conditions: Intracerebral Hemorrhage; Stroke; Hypertension
Intervention: Other: Blood pressure management policies
Sponsors: The George Institute; The George Institute; National Health and Medical Research Council, Australia
Recruiting - verified February 2012 - Condition: Pandemic Influenza
Intervention:
Sponsors: Kirby Institute; Kirby Institute; National Health and Medical Research Council, Australia
Withdrawn - verified April 2012 - Condition: Pandemic Influenza
Intervention:
Sponsors: Kirby Institute; Kirby Institute; National Health and Medical Research Council, Australia
Withdrawn - verified April 2012 - Condition: Pandemic Influenza
Intervention:
Sponsors: Kirby Institute; Kirby Institute; National Health and Medical Research Council, Australia
Withdrawn - verified April 2012 - Condition: Cervical Cancer
Interventions: Procedure: Total Abdominal Radical Hysterectomy; Procedure: Total Laparoscopic or Robotic Radical Hysterectomy
Sponsors: Queensland Centre for Gynaecological Cancer; Queensland Centre for Gynaecological Cancer; M.D. Anderson Cancer Center
Recruiting - verified June 2011 - Conditions: Female Genital Diseases; Ovarian Cancer; Cervical Cancer; Endometrial Cancer; Vulval Cancer
Intervention:
Sponsors: Queensland Centre for Gynaecological Cancer; Queensland Centre for Gynaecological Cancer; The University of Queensland; Royal Brisbane and Women's Hospital; Mater Health Services, Brisbane; Mater Private Hospital; Queensland Institute of Medical Research; Queensland University of Technology; Australia New Zealand Gynaecological Oncology Group; Cancer Australia
Active, not recruiting - verified June 2011 - Conditions: Fallopian Tube Cancer; Ovarian Cancer; Primary Peritoneal Cavity Cancer
Interventions: Biological: bevacizumab; Drug: carboplatin; Drug: paclitaxel; Other: questionnaire administration; Other: study of socioeconomic and demographic variables; Procedure: quality-of-life assessment
Sponsors: National Cancer Institute (NCI); Medical Research Council
Recruiting - verified April 2012 - Condition: Prostate Cancer
Interventions: Procedure: 7800 cGy/39 fractions in 8 weeks; Procedure: 6000 cGy/20 fractions in 4 weeks
Sponsors: Ontario Clinical Oncology Group (OCOG); Ontario Clinical Oncology Group (OCOG); Canadian Institutes of Health Research (CIHR); Trans-Tasman Radiation Oncology Group (TROG)
Active, not recruiting - verified October 2011 - Condition: Brain and Central Nervous System Tumors
Interventions: Drug: temozolomide; Radiation: radiation therapy
Sponsors: European Organization for Research and Treatment of Cancer - EORTC; European Organization for Research and Treatment of Cancer - EORTC; NCIC Clinical Trials Group; British Medical Research Council; Trans-Tasman Radiation Oncology Group (TROG)
Active, not recruiting - verified February 2012 - Condition: Uterine Cancer
Intervention: Drug: Paclitaxel, Carboplatin
Sponsors: Queensland Centre for Gynaecological Cancer; Queensland Centre for Gynaecological Cancer
Completed - verified February 2012 - Condition: HIV Infections
Interventions: Drug: ondansetron, ibuprofen, paracetamol; Drug: Ondansetron, ibuprofen, paracetamol; Drug: metoclopramide, ibuprofen, paracetamol; Drug: Metoclopramide, codeine phosphate, ibuprofen, paracetamol
Sponsors: Kirby Institute; Kirby Institute; The University of New South Wales
Terminated - verified April 2012 - Condition: Radiation Injuries
Interventions: Procedure: Hyperbaric Oxygen Therapy; Procedure: Sham treatment
Sponsors: Baromedical Research Foundation; Baromedical Research Foundation
Terminated - verified February 2012 - Condition: Patellofemoral Pain Syndrome
Interventions: Procedure: Foot Orthotics; Procedure: Physiotherapy
Sponsors: The University of Queensland; The University of Queensland; National Health and Medical Research Council, Australia
Active, not recruiting - verified September 2006 - Condition: Brain and Central Nervous System Tumors
Interventions: Biological: filgrastim; Drug: cisplatin; Drug: cyclophosphamide; Drug: vincristine sulfate; Procedure: autologous hematopoietic stem cell transplantation; Radiation: radiation therapy
Sponsors: St. Jude Children's Research Hospital; St. Jude Children's Research Hospital
Recruiting - verified January 2012
 |
Join Clinical Trials by University in Queensland, Australia |
